

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of relaxation of muscle (GO:1901077) | 8.13151364 |
| 2 | response to muscle activity (GO:0014850) | 7.94389235 |
| 3 | actin filament-based movement (GO:0030048) | 7.90216295 |
| 4 | myofibril assembly (GO:0030239) | 7.56223662 |
| 5 | creatine metabolic process (GO:0006600) | 7.54265757 |
| 6 | striated muscle contraction (GO:0006941) | 7.48613158 |
| 7 | skeletal muscle fiber development (GO:0048741) | 6.94735914 |
| 8 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.93825166 |
| 9 | sarcomere organization (GO:0045214) | 6.83773126 |
| 10 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.83342310 |
| 11 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.29207471 |
| 12 | myotube cell development (GO:0014904) | 6.26839864 |
| 13 | plasma membrane repair (GO:0001778) | 6.13728181 |
| 14 | response to inactivity (GO:0014854) | 6.08485376 |
| 15 | proteasome assembly (GO:0043248) | 6.01102502 |
| 16 | glycogen catabolic process (GO:0005980) | 6.00342843 |
| 17 | skeletal muscle adaptation (GO:0043501) | 5.96153356 |
| 18 | muscle contraction (GO:0006936) | 5.88249459 |
| 19 | glucan catabolic process (GO:0009251) | 5.64893443 |
| 20 | intestinal epithelial cell development (GO:0060576) | 5.55993049 |
| 21 | purine nucleobase biosynthetic process (GO:0009113) | 5.53455624 |
| 22 | cardiac myofibril assembly (GO:0055003) | 5.41785677 |
| 23 | glucan biosynthetic process (GO:0009250) | 5.31912973 |
| 24 | glycogen biosynthetic process (GO:0005978) | 5.31912973 |
| 25 | cellular polysaccharide catabolic process (GO:0044247) | 5.29367719 |
| 26 | muscle system process (GO:0003012) | 5.24600765 |
| 27 | actomyosin structure organization (GO:0031032) | 5.19636509 |
| 28 | muscle fiber development (GO:0048747) | 5.17589514 |
| 29 | folic acid metabolic process (GO:0046655) | 5.16816059 |
| 30 | cardiac muscle contraction (GO:0060048) | 5.15777222 |
| 31 | ribosome assembly (GO:0042255) | 5.13148574 |
| 32 | regulation of cell communication by electrical coupling (GO:0010649) | 4.92204014 |
| 33 | nucleobase biosynthetic process (GO:0046112) | 4.88067362 |
| 34 | muscle cell cellular homeostasis (GO:0046716) | 4.84580373 |
| 35 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 4.84345673 |
| 36 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 4.84016428 |
| 37 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 4.84006752 |
| 38 | skeletal muscle tissue development (GO:0007519) | 4.82765318 |
| 39 | regulation of cellular amino acid metabolic process (GO:0006521) | 4.77789062 |
| 40 | polysaccharide catabolic process (GO:0000272) | 4.77258601 |
| 41 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 4.70387660 |
| 42 | regulation of actin filament-based movement (GO:1903115) | 4.68847600 |
| 43 | folic acid transport (GO:0015884) | 4.67663613 |
| 44 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 4.66457670 |
| 45 | skeletal muscle tissue regeneration (GO:0043403) | 4.65439034 |
| 46 | interferon-gamma secretion (GO:0072643) | 4.64021560 |
| 47 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 4.56997635 |
| 48 | striated muscle adaptation (GO:0014888) | 4.52279869 |
| 49 | cardiac muscle hypertrophy (GO:0003300) | 4.51662981 |
| 50 | DNA deamination (GO:0045006) | 4.49083760 |
| 51 | regulation of mitochondrial translation (GO:0070129) | 4.43969689 |
| 52 | negative regulation of ligase activity (GO:0051352) | 4.34860988 |
| 53 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 4.34860988 |
| 54 | glycogen metabolic process (GO:0005977) | 4.33241099 |
| 55 | striated muscle hypertrophy (GO:0014897) | 4.30874960 |
| 56 | ribosomal large subunit biogenesis (GO:0042273) | 4.29831793 |
| 57 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 4.25293515 |
| 58 | cellular glucan metabolic process (GO:0006073) | 4.24800485 |
| 59 | glucan metabolic process (GO:0044042) | 4.24800485 |
| 60 | response to activity (GO:0014823) | 4.21927002 |
| 61 | 2-oxoglutarate metabolic process (GO:0006103) | 4.20495407 |
| 62 | formation of translation preinitiation complex (GO:0001731) | 4.18623768 |
| 63 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 4.15900807 |
| 64 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 4.15900807 |
| 65 | muscle organ morphogenesis (GO:0048644) | 4.14793068 |
| 66 | GDP-mannose metabolic process (GO:0019673) | 4.12973025 |
| 67 | rRNA modification (GO:0000154) | 4.10470884 |
| 68 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 4.09692848 |
| 69 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 4.09692848 |
| 70 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 4.09692848 |
| 71 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 4.08686485 |
| 72 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.08025026 |
| 73 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 4.07754291 |
| 74 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.06827084 |
| 75 | muscle cell fate commitment (GO:0042693) | 4.02597562 |
| 76 | muscle structure development (GO:0061061) | 4.00832837 |
| 77 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 3.99513208 |
| 78 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 3.99513208 |
| 79 | muscle organ development (GO:0007517) | 3.98741335 |
| 80 | neuronal action potential propagation (GO:0019227) | 3.98638478 |
| 81 | positive regulation of ligase activity (GO:0051351) | 3.98569247 |
| 82 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.95540675 |
| 83 | striated muscle cell development (GO:0055002) | 3.93126631 |
| 84 | amino acid salvage (GO:0043102) | 3.92340797 |
| 85 | L-methionine salvage (GO:0071267) | 3.92340797 |
| 86 | L-methionine biosynthetic process (GO:0071265) | 3.92340797 |
| 87 | maturation of SSU-rRNA (GO:0030490) | 3.89345016 |
| 88 | NADH metabolic process (GO:0006734) | 3.85876857 |
| 89 | positive regulation of myotube differentiation (GO:0010831) | 3.83479051 |
| 90 | muscle hypertrophy (GO:0014896) | 3.82265683 |
| 91 | tricarboxylic acid cycle (GO:0006099) | 3.79812583 |
| 92 | blastocyst development (GO:0001824) | 3.79074736 |
| 93 | striated muscle atrophy (GO:0014891) | 3.78436252 |
| 94 | IMP metabolic process (GO:0046040) | 3.77233676 |
| 95 | regulation of striated muscle contraction (GO:0006942) | 3.76367455 |
| 96 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.73356327 |
| 97 | adult heart development (GO:0007512) | 3.71155003 |
| 98 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 3.69154905 |
| 99 | * gluconeogenesis (GO:0006094) | 3.68852589 |
| 100 | amino sugar catabolic process (GO:0046348) | 3.68265268 |
| 101 | myoblast fusion (GO:0007520) | 3.66936127 |
| 102 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.66788687 |
| 103 | muscle adaptation (GO:0043500) | 3.65114055 |
| 104 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 3.64936827 |
| 105 | muscle tissue morphogenesis (GO:0060415) | 3.64103988 |
| 106 | ubiquinone biosynthetic process (GO:0006744) | 3.62973998 |
| 107 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.58840025 |
| 108 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.58840025 |
| 109 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.56558353 |
| 110 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.55543059 |
| 111 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.55543059 |
| 112 | AMP metabolic process (GO:0046033) | 3.55387999 |
| 113 | ATP synthesis coupled proton transport (GO:0015986) | 3.53119290 |
| 114 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.53119290 |
| 115 | neuromuscular synaptic transmission (GO:0007274) | 3.51817248 |
| 116 | ribosome biogenesis (GO:0042254) | 3.51576720 |
| 117 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.51515060 |
| 118 | carnitine shuttle (GO:0006853) | 3.48900451 |
| 119 | mitotic metaphase plate congression (GO:0007080) | 3.48616576 |
| 120 | regulation of translation in response to stress (GO:0043555) | 3.47101099 |
| 121 | muscle atrophy (GO:0014889) | 3.47039965 |
| 122 | regulation of myoblast differentiation (GO:0045661) | 3.46898602 |
| 123 | lung-associated mesenchyme development (GO:0060484) | 3.46395285 |
| 124 | regulation of ligase activity (GO:0051340) | 3.45093424 |
| 125 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.44201165 |
| 126 | cellular carbohydrate catabolic process (GO:0044275) | 3.43370284 |
| 127 | cardiac muscle cell development (GO:0055013) | 3.43338639 |
| 128 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.42570437 |
| 129 | regulation of cellular amine metabolic process (GO:0033238) | 3.42300645 |
| 130 | negative regulation of muscle contraction (GO:0045932) | 3.41865129 |
| 131 | positive regulation of cell cycle arrest (GO:0071158) | 3.41839892 |
| 132 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.40066428 |
| 133 | muscle cell development (GO:0055001) | 3.38829317 |
| 134 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.37798332 |
| 135 | muscle hypertrophy in response to stress (GO:0003299) | 3.37798332 |
| 136 | cardiac muscle adaptation (GO:0014887) | 3.37798332 |
| 137 | DNA damage response, detection of DNA damage (GO:0042769) | 3.37220017 |
| 138 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.35840481 |
| 139 | termination of RNA polymerase III transcription (GO:0006386) | 3.35840481 |
| 140 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.33307780 |
| 141 | modified amino acid transport (GO:0072337) | 3.33123814 |
| 142 | myotube differentiation (GO:0014902) | 3.33032368 |
| 143 | ADP metabolic process (GO:0046031) | 3.30377073 |
| 144 | N-acetylneuraminate metabolic process (GO:0006054) | 3.30043102 |
| 145 | * hexose biosynthetic process (GO:0019319) | 3.29431762 |
| 146 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.28316091 |
| 147 | ubiquinone metabolic process (GO:0006743) | 3.26153467 |
| 148 | striated muscle tissue development (GO:0014706) | 3.25428639 |
| 149 | relaxation of muscle (GO:0090075) | 3.23964274 |
| 150 | DNA replication checkpoint (GO:0000076) | 3.23843885 |
| 151 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.20699977 |
| 152 | regulation of skeletal muscle cell differentiation (GO:2001014) | 3.20655275 |
| 153 | translational initiation (GO:0006413) | 3.20085646 |
| 154 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.20004032 |
| 155 | succinate metabolic process (GO:0006105) | 3.19521108 |
| 156 | methionine biosynthetic process (GO:0009086) | 3.18968854 |
| 157 | cardiac cell development (GO:0055006) | 3.18504155 |
| 158 | galactose catabolic process (GO:0019388) | 3.18126820 |
| 159 | termination of RNA polymerase I transcription (GO:0006363) | 3.18081090 |
| 160 | syncytium formation by plasma membrane fusion (GO:0000768) | 3.17858671 |
| 161 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.17367457 |
| 162 | transcription from RNA polymerase I promoter (GO:0006360) | 3.15548720 |
| 163 | labyrinthine layer development (GO:0060711) | 3.15064998 |
| 164 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.14978866 |
| 165 | translation (GO:0006412) | 3.14700707 |
| 166 | 7-methylguanosine mRNA capping (GO:0006370) | 3.13918837 |
| 167 | ribosomal small subunit biogenesis (GO:0042274) | 3.13753899 |
| 168 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.10275583 |
| 169 | DNA damage response, signal transduction by p53 class mediator (GO:0030330) | 3.06461070 |
| 170 | rRNA processing (GO:0006364) | 3.05450450 |
| 171 | sulfur amino acid biosynthetic process (GO:0000097) | 3.05079728 |
| 172 | cell cycle G1/S phase transition (GO:0044843) | 3.03221105 |
| 173 | G1/S transition of mitotic cell cycle (GO:0000082) | 3.03221105 |
| 174 | CDP-diacylglycerol metabolic process (GO:0046341) | 3.02865094 |
| 175 | negative regulation of translational initiation (GO:0045947) | 3.00659778 |
| 176 | establishment of protein localization to mitochondrion (GO:0072655) | 2.99561720 |
| 177 | cellular component biogenesis (GO:0044085) | 2.99265590 |
| 178 | methionine metabolic process (GO:0006555) | 2.99007656 |
| 179 | 7-methylguanosine RNA capping (GO:0009452) | 2.98058804 |
| 180 | RNA capping (GO:0036260) | 2.98058804 |
| 181 | rRNA metabolic process (GO:0016072) | 2.97413435 |
| 182 | negative regulation of protein ubiquitination (GO:0031397) | 2.90294526 |
| 183 | protein localization to mitochondrion (GO:0070585) | 2.88950744 |
| 184 | regulation of spindle organization (GO:0090224) | 2.87744332 |
| 185 | protein targeting to mitochondrion (GO:0006626) | 2.86983206 |
| 186 | oxidative phosphorylation (GO:0006119) | 2.86615439 |
| 187 | keratinocyte development (GO:0003334) | 2.84604798 |
| 188 | translational termination (GO:0006415) | 2.84224322 |
| 189 | chaperone-mediated protein complex assembly (GO:0051131) | 2.84202421 |
| 190 | viral transcription (GO:0019083) | 2.81351366 |
| 191 | signal transduction in response to DNA damage (GO:0042770) | 2.79098499 |
| 192 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.78616936 |
| 193 | pseudouridine synthesis (GO:0001522) | 2.77334661 |
| 194 | muscle filament sliding (GO:0030049) | 12.9625313 |
| 195 | actin-myosin filament sliding (GO:0033275) | 12.9625313 |
| 196 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 11.4998837 |
| 197 | actin-mediated cell contraction (GO:0070252) | 10.6610446 |
| 198 | skeletal muscle contraction (GO:0003009) | 10.5715073 |
| 199 | regulation of skeletal muscle contraction (GO:0014819) | 10.3352345 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.82937687 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.58184813 |
| 3 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 4.75606952 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 4.29515833 |
| 5 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.80122548 |
| 6 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.67373360 |
| 7 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.59919396 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.58047276 |
| 9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.56323479 |
| 10 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.54089192 |
| 11 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 3.44838151 |
| 12 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.37851269 |
| 13 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 3.35650102 |
| 14 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.30542596 |
| 15 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.24962191 |
| 16 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.13242095 |
| 17 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.92889018 |
| 18 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.87977313 |
| 19 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.80224303 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.74270060 |
| 21 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 2.68794509 |
| 22 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 2.68794509 |
| 23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.61205866 |
| 24 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.59248455 |
| 25 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 2.37367510 |
| 26 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.30341624 |
| 27 | * PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 2.29177058 |
| 28 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.26630126 |
| 29 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.25491782 |
| 30 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 2.25271247 |
| 31 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.23468831 |
| 32 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.21522835 |
| 33 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.17190639 |
| 34 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.15922732 |
| 35 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 2.13721048 |
| 36 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.12036405 |
| 37 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.10918568 |
| 38 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.08726646 |
| 39 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.08156849 |
| 40 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.04418543 |
| 41 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 2.00453489 |
| 42 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.99882993 |
| 43 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.99442566 |
| 44 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.98842751 |
| 45 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.96969339 |
| 46 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.96761036 |
| 47 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.95566249 |
| 48 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.92051609 |
| 49 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.91821474 |
| 50 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.91821464 |
| 51 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.82660123 |
| 52 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.79935930 |
| 53 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.75232522 |
| 54 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.70593804 |
| 55 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.70427050 |
| 56 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.69934252 |
| 57 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.69239817 |
| 58 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.68383280 |
| 59 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.68086713 |
| 60 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.67688192 |
| 61 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.64898678 |
| 62 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.64431844 |
| 63 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.58617129 |
| 64 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.58462121 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.56871780 |
| 66 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.54146039 |
| 67 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.52947038 |
| 68 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.49897136 |
| 69 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.48827461 |
| 70 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.46968931 |
| 71 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.44886618 |
| 72 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44271430 |
| 73 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.42929808 |
| 74 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.42353514 |
| 75 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.42137979 |
| 76 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.41732885 |
| 77 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.39742749 |
| 78 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.39676692 |
| 79 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.38833416 |
| 80 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.37083409 |
| 81 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.36901706 |
| 82 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.36428755 |
| 83 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.34653317 |
| 84 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.34492415 |
| 85 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.33237404 |
| 86 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.30959244 |
| 87 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.30685661 |
| 88 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.30239782 |
| 89 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.30144835 |
| 90 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.29165161 |
| 91 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.28837789 |
| 92 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.27106984 |
| 93 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.24981105 |
| 94 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.24584503 |
| 95 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.23543199 |
| 96 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.21502609 |
| 97 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.20256114 |
| 98 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.19179639 |
| 99 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.18910316 |
| 100 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 1.18392172 |
| 101 | OCT4_20526341_ChIP-Seq_ESCs_Human | 1.18070863 |
| 102 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.14187000 |
| 103 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.13750430 |
| 104 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.13060330 |
| 105 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.12459796 |
| 106 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.09889215 |
| 107 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 1.09192173 |
| 108 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.08480610 |
| 109 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07298905 |
| 110 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.06308942 |
| 111 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.03814963 |
| 112 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.03622782 |
| 113 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.02923044 |
| 114 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.02805188 |
| 115 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.02057839 |
| 116 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 1.01348276 |
| 117 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00873023 |
| 118 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.00858400 |
| 119 | SA1_27219007_Chip-Seq_Bcells_Human | 1.00441493 |
| 120 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.00301066 |
| 121 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.00206787 |
| 122 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.00044914 |
| 123 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99814195 |
| 124 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.99759354 |
| 125 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.98565650 |
| 126 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 0.98529830 |
| 127 | ATF3_27146783_Chip-Seq_COLON_Human | 0.98449320 |
| 128 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.98128441 |
| 129 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.97938775 |
| 130 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.97013742 |
| 131 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.97013742 |
| 132 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.97013742 |
| 133 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.96693498 |
| 134 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.96591619 |
| 135 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.96191186 |
| 136 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.95987523 |
| 137 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.95550149 |
| 138 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95109488 |
| 139 | POU5F1_18692474_ChIP-Seq_MESCs_Mouse | 0.94636387 |
| 140 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.94632360 |
| 141 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 0.94509467 |
| 142 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.93074644 |
| 143 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.92855937 |
| 144 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.92411896 |
| 145 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.92256071 |
| 146 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 0.91148570 |
| 147 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.90751727 |
| 148 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.90666966 |
| 149 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.90516612 |
| 150 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.89674701 |
| 151 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.88826935 |
| 152 | VDR_22108803_ChIP-Seq_LS180_Human | 0.88696147 |
| 153 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.88298811 |
| 154 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.88006288 |
| 155 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.87738550 |
| 156 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.87506908 |
| 157 | * MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.87322325 |
| 158 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.87006214 |
| 159 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.86947471 |
| 160 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.85913641 |
| 161 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.85145963 |
| 162 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.85145963 |
| 163 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.84764504 |
| 164 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.84526756 |
| 165 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.84067299 |
| 166 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.83677014 |
| 167 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.83410799 |
| 168 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.83395389 |
| 169 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.82690130 |
| 170 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.82349109 |
| 171 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.78336846 |
| 172 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.78273756 |
| 173 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.77884214 |
| 174 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.76857869 |
| 175 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.76203052 |
| 176 | CBP_21632823_ChIP-Seq_H3396_Human | 0.75337650 |
| 177 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.74686440 |
| 178 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.74682516 |
| 179 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 0.73171239 |
| 180 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.73126215 |
| 181 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.72764656 |
| 182 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72089332 |
| 183 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72089332 |
| 184 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.71115712 |
| 185 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.70712990 |
| 186 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.70336273 |
| 187 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.70061637 |
| 188 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.69858295 |
| 189 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.69159372 |
| 190 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.69151043 |
| 191 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.69069632 |
| 192 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.68648440 |
| 193 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.68598322 |
| 194 | LUZP1_20508642_ChIP-Seq_ESCs_Mouse | 0.68470769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004145_abnormal_muscle_electrophysio | 7.06229748 |
| 2 | MP0003693_abnormal_embryo_hatching | 6.69658175 |
| 3 | MP0000749_muscle_degeneration | 6.08848000 |
| 4 | MP0000751_myopathy | 5.94335734 |
| 5 | MP0004036_abnormal_muscle_relaxation | 4.36831524 |
| 6 | MP0004957_abnormal_blastocyst_morpholog | 4.35998183 |
| 7 | MP0003111_abnormal_nucleus_morphology | 4.04430180 |
| 8 | MP0003806_abnormal_nucleotide_metabolis | 3.92583118 |
| 9 | MP0003718_maternal_effect | 3.90396917 |
| 10 | MP0002106_abnormal_muscle_physiology | 3.79783163 |
| 11 | MP0009840_abnormal_foam_cell | 3.72261792 |
| 12 | MP0000759_abnormal_skeletal_muscle | 3.56463101 |
| 13 | MP0008260_abnormal_autophagy | 3.45128404 |
| 14 | MP0004087_abnormal_muscle_fiber | 3.40486700 |
| 15 | MP0005369_muscle_phenotype | 3.24483782 |
| 16 | MP0002332_abnormal_exercise_endurance | 3.08570060 |
| 17 | MP0004233_abnormal_muscle_weight | 3.04598392 |
| 18 | MP0005620_abnormal_muscle_contractility | 2.83760598 |
| 19 | MP0004130_abnormal_muscle_cell | 2.73214453 |
| 20 | MP0003315_abnormal_perineum_morphology | 2.53722720 |
| 21 | MP0003077_abnormal_cell_cycle | 2.52606474 |
| 22 | MP0003878_abnormal_ear_physiology | 2.51715851 |
| 23 | MP0005377_hearing/vestibular/ear_phenot | 2.51715851 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 2.26727404 |
| 25 | MP0010094_abnormal_chromosome_stability | 2.20762308 |
| 26 | MP0008932_abnormal_embryonic_tissue | 2.20651039 |
| 27 | MP0000733_abnormal_muscle_development | 2.20052962 |
| 28 | MP0005360_urolithiasis | 2.19322358 |
| 29 | MP0010352_gastrointestinal_tract_polyps | 2.18767297 |
| 30 | MP0002837_dystrophic_cardiac_calcinosis | 2.17223941 |
| 31 | MP0003646_muscle_fatigue | 2.11276408 |
| 32 | MP0001730_embryonic_growth_arrest | 2.04550885 |
| 33 | MP0002108_abnormal_muscle_morphology | 2.04138037 |
| 34 | MP0002972_abnormal_cardiac_muscle | 2.03376143 |
| 35 | MP0004264_abnormal_extraembryonic_tissu | 1.90817853 |
| 36 | MP0001666_abnormal_nutrient_absorption | 1.90644919 |
| 37 | MP0005451_abnormal_body_composition | 1.87601799 |
| 38 | MP0008058_abnormal_DNA_repair | 1.80160653 |
| 39 | MP0000490_abnormal_crypts_of | 1.76038432 |
| 40 | MP0001756_abnormal_urination | 1.72653663 |
| 41 | MP0003786_premature_aging | 1.71186624 |
| 42 | MP0003567_abnormal_fetal_cardiomyocyte | 1.69949958 |
| 43 | MP0004270_analgesia | 1.66700887 |
| 44 | MP0000013_abnormal_adipose_tissue | 1.60958591 |
| 45 | MP0006035_abnormal_mitochondrial_morpho | 1.60094799 |
| 46 | MP0005395_other_phenotype | 1.58180488 |
| 47 | MP0005332_abnormal_amino_acid | 1.56894617 |
| 48 | MP0003866_abnormal_defecation | 1.53552116 |
| 49 | MP0000537_abnormal_urethra_morphology | 1.46318691 |
| 50 | MP0003941_abnormal_skin_development | 1.43598569 |
| 51 | MP0000462_abnormal_digestive_system | 1.42818703 |
| 52 | MP0006036_abnormal_mitochondrial_physio | 1.42048459 |
| 53 | MP0010630_abnormal_cardiac_muscle | 1.41806418 |
| 54 | MP0002127_abnormal_cardiovascular_syste | 1.39053453 |
| 55 | MP0005085_abnormal_gallbladder_physiolo | 1.38743280 |
| 56 | MP0004084_abnormal_cardiac_muscle | 1.30370190 |
| 57 | MP0006138_congestive_heart_failure | 1.29541183 |
| 58 | MP0001672_abnormal_embryogenesis/_devel | 1.27945969 |
| 59 | MP0005380_embryogenesis_phenotype | 1.27945969 |
| 60 | MP0003950_abnormal_plasma_membrane | 1.26704468 |
| 61 | MP0000350_abnormal_cell_proliferation | 1.26614592 |
| 62 | MP0001544_abnormal_cardiovascular_syste | 1.26431674 |
| 63 | MP0005385_cardiovascular_system_phenoty | 1.26431674 |
| 64 | MP0001542_abnormal_bone_strength | 1.26048945 |
| 65 | MP0004510_myositis | 1.24060306 |
| 66 | MP0005670_abnormal_white_adipose | 1.22552895 |
| 67 | MP0009643_abnormal_urine_homeostasis | 1.19891688 |
| 68 | MP0008875_abnormal_xenobiotic_pharmacok | 1.19814355 |
| 69 | MP0001727_abnormal_embryo_implantation | 1.19285302 |
| 70 | MP0002822_catalepsy | 1.17890503 |
| 71 | MP0000477_abnormal_intestine_morphology | 1.17861464 |
| 72 | MP0003186_abnormal_redox_activity | 1.15548385 |
| 73 | MP0002080_prenatal_lethality | 1.13916387 |
| 74 | MP0002796_impaired_skin_barrier | 1.11812962 |
| 75 | MP0003984_embryonic_growth_retardation | 1.11528711 |
| 76 | MP0002088_abnormal_embryonic_growth/wei | 1.10452627 |
| 77 | MP0000358_abnormal_cell_content/ | 1.08144782 |
| 78 | MP0002971_abnormal_brown_adipose | 1.08037025 |
| 79 | MP0001661_extended_life_span | 1.04769509 |
| 80 | MP0003221_abnormal_cardiomyocyte_apopto | 1.03965941 |
| 81 | MP0002269_muscular_atrophy | 1.00790719 |
| 82 | MP0008057_abnormal_DNA_replication | 1.00556904 |
| 83 | MP0004185_abnormal_adipocyte_glucose | 0.99287448 |
| 84 | MP0001697_abnormal_embryo_size | 0.97737341 |
| 85 | MP0003123_paternal_imprinting | 0.95933615 |
| 86 | MP0002086_abnormal_extraembryonic_tissu | 0.95025143 |
| 87 | MP0001764_abnormal_homeostasis | 0.93791791 |
| 88 | MP0005389_reproductive_system_phenotype | 0.93292548 |
| 89 | MP0000750_abnormal_muscle_regeneration | 0.92276683 |
| 90 | MP0000747_muscle_weakness | 0.91741961 |
| 91 | MP0005266_abnormal_metabolism | 0.90127188 |
| 92 | MP0005330_cardiomyopathy | 0.89895691 |
| 93 | MP0010234_abnormal_vibrissa_follicle | 0.87077170 |
| 94 | MP0005058_abnormal_lysosome_morphology | 0.85684604 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 0.84548063 |
| 96 | MP0001919_abnormal_reproductive_system | 0.84510140 |
| 97 | MP0002277_abnormal_respiratory_mucosa | 0.84348345 |
| 98 | MP0008007_abnormal_cellular_replicative | 0.83686069 |
| 99 | MP0002085_abnormal_embryonic_tissue | 0.83245526 |
| 100 | MP0009780_abnormal_chondrocyte_physiolo | 0.82349512 |
| 101 | MP0003137_abnormal_impulse_conducting | 0.81989468 |
| 102 | MP0004043_abnormal_pH_regulation | 0.81570651 |
| 103 | MP0005375_adipose_tissue_phenotype | 0.80156772 |
| 104 | MP0005666_abnormal_adipose_tissue | 0.80129170 |
| 105 | MP0008775_abnormal_heart_ventricle | 0.78119961 |
| 106 | MP0002160_abnormal_reproductive_system | 0.77763529 |
| 107 | MP0000313_abnormal_cell_death | 0.77249838 |
| 108 | MP0009333_abnormal_splenocyte_physiolog | 0.76884516 |
| 109 | MP0000003_abnormal_adipose_tissue | 0.75259893 |
| 110 | MP0000627_abnormal_mammary_gland | 0.75114365 |
| 111 | MP0001145_abnormal_male_reproductive | 0.73005084 |
| 112 | MP0005408_hypopigmentation | 0.72441541 |
| 113 | MP0004147_increased_porphyrin_level | 0.71371451 |
| 114 | MP0002132_abnormal_respiratory_system | 0.70161313 |
| 115 | MP0004484_altered_response_of | 0.69622009 |
| 116 | MP0005636_abnormal_mineral_homeostasis | 0.69521489 |
| 117 | MP0002139_abnormal_hepatobiliary_system | 0.69186405 |
| 118 | MP0010329_abnormal_lipoprotein_level | 0.68952844 |
| 119 | MP0000372_irregular_coat_pigmentation | 0.68172617 |
| 120 | MP0002210_abnormal_sex_determination | 0.67781474 |
| 121 | MP0003119_abnormal_digestive_system | 0.67051629 |
| 122 | MP0005365_abnormal_bile_salt | 0.66818366 |
| 123 | MP0003195_calcinosis | 0.66430944 |
| 124 | MP0004085_abnormal_heartbeat | 0.66122526 |
| 125 | MP0003938_abnormal_ear_development | 0.66040324 |
| 126 | MP0005367_renal/urinary_system_phenotyp | 0.65335394 |
| 127 | MP0000516_abnormal_urinary_system | 0.65335394 |
| 128 | MP0004215_abnormal_myocardial_fiber | 0.63977177 |
| 129 | MP0005381_digestive/alimentary_phenotyp | 0.63378901 |
| 130 | MP0009053_abnormal_anal_canal | 0.62924712 |
| 131 | MP0008877_abnormal_DNA_methylation | 0.62763739 |
| 132 | MP0001663_abnormal_digestive_system | 0.62041608 |
| 133 | MP0003879_abnormal_hair_cell | 0.61976079 |
| 134 | MP0002136_abnormal_kidney_physiology | 0.61064360 |
| 135 | MP0001849_ear_inflammation | 0.60675721 |
| 136 | MP0009379_abnormal_foot_pigmentation | 0.60427815 |
| 137 | MP0003656_abnormal_erythrocyte_physiolo | 0.58420910 |
| 138 | MP0000266_abnormal_heart_morphology | 0.57234003 |
| 139 | MP0010030_abnormal_orbit_morphology | 0.57093723 |
| 140 | MP0001299_abnormal_eye_distance/ | 0.54991693 |
| 141 | MP0004134_abnormal_chest_morphology | 0.53536834 |
| 142 | MP0002078_abnormal_glucose_homeostasis | 0.52170462 |
| 143 | MP0002638_abnormal_pupillary_reflex | 0.51029839 |
| 144 | MP0005167_abnormal_blood-brain_barrier | 0.49203419 |
| 145 | MP0003828_pulmonary_edema | 0.48399512 |
| 146 | MP0005083_abnormal_biliary_tract | 0.48309187 |
| 147 | MP0003045_fibrosis | 0.47392071 |
| 148 | MP0004142_abnormal_muscle_tone | 0.46106889 |
| 149 | MP0001529_abnormal_vocalization | 0.44745888 |
| 150 | MP0001346_abnormal_lacrimal_gland | 0.44667378 |
| 151 | MP0005376_homeostasis/metabolism_phenot | 0.43560870 |
| 152 | MP0005423_abnormal_somatic_nervous | 0.42355454 |
| 153 | MP0000762_abnormal_tongue_morphology | 0.39633298 |
| 154 | MP0009672_abnormal_birth_weight | 0.39333965 |
| 155 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.38376513 |
| 156 | MP0002114_abnormal_axial_skeleton | 0.37859128 |
| 157 | MP0008569_lethality_at_weaning | 0.37823510 |
| 158 | MP0002734_abnormal_mechanical_nocicepti | 0.37700563 |
| 159 | MP0009250_abnormal_appendicular_skeleto | 0.36210794 |
| 160 | MP0005452_abnormal_adipose_tissue | 0.35522101 |
| 161 | MP0006276_abnormal_autonomic_nervous | 0.33837798 |
| 162 | MP0005187_abnormal_penis_morphology | 0.33656345 |
| 163 | MP0002128_abnormal_blood_circulation | 0.30892876 |
| 164 | MP0005535_abnormal_body_temperature | 0.30185722 |
| 165 | MP0003948_abnormal_gas_homeostasis | 0.30042764 |
| 166 | MP0005166_decreased_susceptibility_to | 0.29858844 |
| 167 | MP0002066_abnormal_motor_capabilities/c | 0.27475672 |
| 168 | MP0005334_abnormal_fat_pad | 0.26881923 |
| 169 | MP0001943_abnormal_respiration | 0.26058264 |
| 170 | MP0008789_abnormal_olfactory_epithelium | 0.25779195 |
| 171 | MP0002896_abnormal_bone_mineralization | 0.25743623 |
| 172 | MP0000230_abnormal_systemic_arterial | 0.23959648 |
| 173 | MP0001984_abnormal_olfaction | 0.21891490 |
| 174 | MP0002067_abnormal_sensory_capabilities | 0.20956995 |
| 175 | MP0004924_abnormal_behavior | 0.19131996 |
| 176 | MP0005386_behavior/neurological_phenoty | 0.19131996 |
| 177 | MP0004197_abnormal_fetal_growth/weight/ | 0.17952032 |
| 178 | MP0002249_abnormal_larynx_morphology | 0.17630181 |
| 179 | MP0005645_abnormal_hypothalamus_physiol | 0.17473908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 8.61839854 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 8.06717987 |
| 3 | Type 1 muscle fiber predominance (HP:0003803) | 8.06596406 |
| 4 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.46073747 |
| 5 | Distal arthrogryposis (HP:0005684) | 6.33681585 |
| 6 | Calf muscle hypertrophy (HP:0008981) | 5.68442945 |
| 7 | EMG: myopathic abnormalities (HP:0003458) | 5.31329693 |
| 8 | Rhabdomyolysis (HP:0003201) | 5.09878819 |
| 9 | Round ear (HP:0100830) | 5.09279926 |
| 10 | Myoglobinuria (HP:0002913) | 5.05704847 |
| 11 | Ulnar deviation of the wrist (HP:0003049) | 4.80825678 |
| 12 | Hyporeflexia of lower limbs (HP:0002600) | 4.69024025 |
| 13 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 4.63749418 |
| 14 | Rimmed vacuoles (HP:0003805) | 4.62306750 |
| 15 | Abnormality of the calf musculature (HP:0001430) | 4.61350382 |
| 16 | Neck muscle weakness (HP:0000467) | 4.44179756 |
| 17 | Calcaneovalgus deformity (HP:0001848) | 4.29146020 |
| 18 | Abnormality of skeletal muscle fiber size (HP:0012084) | 4.26738620 |
| 19 | Breast hypoplasia (HP:0003187) | 4.17697256 |
| 20 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.08642703 |
| 21 | Subaortic stenosis (HP:0001682) | 4.08642703 |
| 22 | Cerebral hypomyelination (HP:0006808) | 4.00254927 |
| 23 | Muscle stiffness (HP:0003552) | 3.94480195 |
| 24 | Carpal bone hypoplasia (HP:0001498) | 3.90832275 |
| 25 | Difficulty running (HP:0009046) | 3.89867417 |
| 26 | Hyperglycinuria (HP:0003108) | 3.84486007 |
| 27 | Deformed tarsal bones (HP:0008119) | 3.82307942 |
| 28 | Rough bone trabeculation (HP:0100670) | 3.80912977 |
| 29 | Absent phalangeal crease (HP:0006109) | 3.78167193 |
| 30 | Ileus (HP:0002595) | 3.68763098 |
| 31 | Increased connective tissue (HP:0009025) | 3.59499480 |
| 32 | Increased variability in muscle fiber diameter (HP:0003557) | 3.51548738 |
| 33 | Myotonia (HP:0002486) | 3.50659612 |
| 34 | Frequent falls (HP:0002359) | 3.47837836 |
| 35 | Hyperglycinemia (HP:0002154) | 3.39124627 |
| 36 | Malignant hyperthermia (HP:0002047) | 3.35779244 |
| 37 | Abnormality of the umbilical cord (HP:0010881) | 3.34953514 |
| 38 | Hepatic necrosis (HP:0002605) | 3.30819979 |
| 39 | Distal lower limb muscle weakness (HP:0009053) | 3.29985031 |
| 40 | Proximal tubulopathy (HP:0000114) | 3.27283408 |
| 41 | Ureteral duplication (HP:0000073) | 3.22053600 |
| 42 | Areflexia of lower limbs (HP:0002522) | 3.21261027 |
| 43 | Nausea (HP:0002018) | 3.18119500 |
| 44 | Birth length less than 3rd percentile (HP:0003561) | 3.15969163 |
| 45 | Asymmetric septal hypertrophy (HP:0001670) | 3.15880196 |
| 46 | Abnormal finger flexion creases (HP:0006143) | 3.15331406 |
| 47 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.11868339 |
| 48 | Abnormality of glycine metabolism (HP:0010895) | 3.11868339 |
| 49 | Ventricular fibrillation (HP:0001663) | 3.08883394 |
| 50 | Sudden death (HP:0001699) | 3.07467941 |
| 51 | Multiple enchondromatosis (HP:0005701) | 3.07293468 |
| 52 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 3.04607536 |
| 53 | Dicarboxylic aciduria (HP:0003215) | 3.04607536 |
| 54 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.99027309 |
| 55 | Abnormality of alanine metabolism (HP:0010916) | 2.99027309 |
| 56 | Hyperalaninemia (HP:0003348) | 2.99027309 |
| 57 | Megaloblastic anemia (HP:0001889) | 2.98237472 |
| 58 | Macrocytic anemia (HP:0001972) | 2.97394392 |
| 59 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.91553487 |
| 60 | Secondary amenorrhea (HP:0000869) | 2.87280236 |
| 61 | EMG: neuropathic changes (HP:0003445) | 2.86812787 |
| 62 | Abnormal trabecular bone morphology (HP:0100671) | 2.83390473 |
| 63 | Progressive muscle weakness (HP:0003323) | 2.81183647 |
| 64 | CNS demyelination (HP:0007305) | 2.77140705 |
| 65 | Generalized muscle weakness (HP:0003324) | 2.75182940 |
| 66 | Aplasia/Hypoplasia involving the carpal bones (HP:0006502) | 2.74280448 |
| 67 | Patent foramen ovale (HP:0001655) | 2.73059191 |
| 68 | Glycosuria (HP:0003076) | 2.72708687 |
| 69 | Abnormality of urine glucose concentration (HP:0011016) | 2.72708687 |
| 70 | Premature ovarian failure (HP:0008209) | 2.70343519 |
| 71 | Hepatocellular necrosis (HP:0001404) | 2.69527988 |
| 72 | Scapular winging (HP:0003691) | 2.67146948 |
| 73 | Increased hepatocellular lipid droplets (HP:0006565) | 2.66632506 |
| 74 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.66429978 |
| 75 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.63375537 |
| 76 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.62360347 |
| 77 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.62360347 |
| 78 | Lethargy (HP:0001254) | 2.60970089 |
| 79 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.60174777 |
| 80 | Lipid accumulation in hepatocytes (HP:0006561) | 2.58971658 |
| 81 | Death in infancy (HP:0001522) | 2.58500091 |
| 82 | Limb-girdle muscle atrophy (HP:0003797) | 2.56971182 |
| 83 | Increased serum lactate (HP:0002151) | 2.55937972 |
| 84 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.55468315 |
| 85 | Single umbilical artery (HP:0001195) | 2.55468315 |
| 86 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.55468315 |
| 87 | Bulbar palsy (HP:0001283) | 2.55451524 |
| 88 | Fetal akinesia sequence (HP:0001989) | 2.52831767 |
| 89 | Myopathic facies (HP:0002058) | 2.51541333 |
| 90 | Microretrognathia (HP:0000308) | 2.50794483 |
| 91 | Weak cry (HP:0001612) | 2.50750170 |
| 92 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.50230984 |
| 93 | Abnormality of the calcaneus (HP:0008364) | 2.48520096 |
| 94 | Abnormality of the anterior horn cell (HP:0006802) | 2.47989880 |
| 95 | Degeneration of anterior horn cells (HP:0002398) | 2.47989880 |
| 96 | Impulsivity (HP:0100710) | 2.45069676 |
| 97 | Abnormal number of erythroid precursors (HP:0012131) | 2.43784819 |
| 98 | Abnormalities of placenta or umbilical cord (HP:0001194) | 2.43677698 |
| 99 | 3-Methylglutaconic aciduria (HP:0003535) | 2.42895417 |
| 100 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.42783689 |
| 101 | Abnormality of serum amino acid levels (HP:0003112) | 2.42581963 |
| 102 | Increased CSF lactate (HP:0002490) | 2.41709089 |
| 103 | Gout (HP:0001997) | 2.41082189 |
| 104 | Distal lower limb amyotrophy (HP:0008944) | 2.40944032 |
| 105 | Prolonged neonatal jaundice (HP:0006579) | 2.40464921 |
| 106 | Aplasia/Hypoplasia of the patella (HP:0006498) | 2.40404222 |
| 107 | Slender build (HP:0001533) | 2.39701098 |
| 108 | Bundle branch block (HP:0011710) | 2.38119744 |
| 109 | Trismus (HP:0000211) | 2.37868659 |
| 110 | Dilated cardiomyopathy (HP:0001644) | 2.36183132 |
| 111 | Hyperkalemia (HP:0002153) | 2.33003513 |
| 112 | Mitochondrial inheritance (HP:0001427) | 2.32759178 |
| 113 | Absent radius (HP:0003974) | 2.32628256 |
| 114 | Gowers sign (HP:0003391) | 2.32265761 |
| 115 | CNS hypomyelination (HP:0003429) | 2.31576334 |
| 116 | Spinal rigidity (HP:0003306) | 2.31366784 |
| 117 | Fatigable weakness (HP:0003473) | 2.29816927 |
| 118 | Abnormality of the neuromuscular junction (HP:0003398) | 2.29816927 |
| 119 | Spastic paraparesis (HP:0002313) | 2.28781263 |
| 120 | Proximal amyotrophy (HP:0007126) | 2.28542684 |
| 121 | Hyperglycemia (HP:0003074) | 2.27806532 |
| 122 | Abnormality of the shoulder girdle musculature (HP:0001435) | 2.25170850 |
| 123 | Congenital, generalized hypertrichosis (HP:0004540) | 2.22875314 |
| 124 | Hypoglycemic coma (HP:0001325) | 2.22845397 |
| 125 | Oral leukoplakia (HP:0002745) | 2.22070343 |
| 126 | Patellar aplasia (HP:0006443) | 2.22044167 |
| 127 | Testicular atrophy (HP:0000029) | 2.21288470 |
| 128 | Sparse eyelashes (HP:0000653) | 2.21153892 |
| 129 | Abnormal biliary tract morphology (HP:0012440) | 2.19071145 |
| 130 | Generalized aminoaciduria (HP:0002909) | 2.17695073 |
| 131 | Muscle fiber splitting (HP:0003555) | 2.16415763 |
| 132 | Athetosis (HP:0002305) | 2.15881342 |
| 133 | Absent forearm bone (HP:0003953) | 2.15299137 |
| 134 | Aplasia involving forearm bones (HP:0009822) | 2.15299137 |
| 135 | Muscular dystrophy (HP:0003560) | 2.14914077 |
| 136 | Lactic acidosis (HP:0003128) | 2.14824537 |
| 137 | Increased intramyocellular lipid droplets (HP:0012240) | 2.14773923 |
| 138 | Absent hand (HP:0004050) | 2.13656755 |
| 139 | Difficulty climbing stairs (HP:0003551) | 2.09728821 |
| 140 | Hip contracture (HP:0003273) | 2.09272905 |
| 141 | Acute necrotizing encephalopathy (HP:0006965) | 2.06523879 |
| 142 | Congenital malformation of the right heart (HP:0011723) | 2.06226902 |
| 143 | Double outlet right ventricle (HP:0001719) | 2.06226902 |
| 144 | Methylmalonic aciduria (HP:0012120) | 2.06024710 |
| 145 | Hyperammonemia (HP:0001987) | 2.06004700 |
| 146 | Ventricular tachycardia (HP:0004756) | 2.05945940 |
| 147 | Abnormality of the foot musculature (HP:0001436) | 2.04049502 |
| 148 | Respiratory failure (HP:0002878) | 2.04000937 |
| 149 | Emotional lability (HP:0000712) | 2.03988968 |
| 150 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.03652769 |
| 151 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.03652769 |
| 152 | Waddling gait (HP:0002515) | 2.01477882 |
| 153 | Increased muscle lipid content (HP:0009058) | 2.00454605 |
| 154 | Muscle fiber inclusion bodies (HP:0100299) | 11.1747454 |
| 155 | Nemaline bodies (HP:0003798) | 10.9065212 |
| 156 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 10.6550956 |
| 157 | Personality changes (HP:0000751) | 1.99887486 |
| 158 | Aplasia/hypoplasia of the humerus (HP:0006507) | 1.99798268 |
| 159 | Shoulder girdle muscle weakness (HP:0003547) | 1.99674820 |
| 160 | Lipoatrophy (HP:0100578) | 1.97329780 |
| 161 | Cheilitis (HP:0100825) | 1.96390239 |
| 162 | Reticulocytopenia (HP:0001896) | 1.95458715 |
| 163 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 1.95137142 |
| 164 | Pelvic girdle muscle weakness (HP:0003749) | 1.93759313 |
| 165 | Stenosis of the external auditory canal (HP:0000402) | 1.93594070 |
| 166 | Exercise intolerance (HP:0003546) | 1.92834062 |
| 167 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.92610074 |
| 168 | Foot dorsiflexor weakness (HP:0009027) | 1.88859270 |
| 169 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.86705681 |
| 170 | Lower limb amyotrophy (HP:0007210) | 1.83465787 |
| 171 | Limb-girdle muscle weakness (HP:0003325) | 1.82912558 |
| 172 | Heart block (HP:0012722) | 1.74397279 |
| 173 | Long clavicles (HP:0000890) | 1.74164188 |
| 174 | Ragged-red muscle fibers (HP:0003200) | 1.72526520 |
| 175 | Nonprogressive disorder (HP:0003680) | 1.71814169 |
| 176 | Metatarsus adductus (HP:0001840) | 1.69336257 |
| 177 | Popliteal pterygium (HP:0009756) | 1.69291427 |
| 178 | Paralysis (HP:0003470) | 1.69074382 |
| 179 | Facial diplegia (HP:0001349) | 1.67225245 |
| 180 | Ulnar deviation of finger (HP:0009465) | 1.62685027 |
| 181 | Abnormal atrioventricular conduction (HP:0005150) | 1.61769784 |
| 182 | Type 2 muscle fiber atrophy (HP:0003554) | 1.59496291 |
| 183 | Muscle fiber atrophy (HP:0100295) | 1.46532660 |
| 184 | Ventricular arrhythmia (HP:0004308) | 1.46339592 |
| 185 | Steppage gait (HP:0003376) | 1.41139368 |
| 186 | Ulnar deviation of the hand or of fingers of the hand (HP:0001193) | 1.37346681 |
| 187 | Limited hip movement (HP:0008800) | 1.37079516 |
| 188 | Oligomenorrhea (HP:0000876) | 1.35831084 |
| 189 | Adducted thumb (HP:0001181) | 1.27635255 |
| 190 | Congenital hip dislocation (HP:0001374) | 1.25658478 |
| 191 | Abnormality of placental membranes (HP:0011409) | 1.22957933 |
| 192 | Amniotic constriction ring (HP:0009775) | 1.22957933 |
| 193 | Short palpebral fissure (HP:0012745) | 1.22716586 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PHKG2 | 6.19443634 |
| 2 | PHKG1 | 6.19443634 |
| 3 | TTN | 5.75715011 |
| 4 | BUB1 | 5.49079500 |
| 5 | EPHA2 | 4.86008481 |
| 6 | WEE1 | 4.83840834 |
| 7 | PNCK | 3.38026377 |
| 8 | STK16 | 3.35044439 |
| 9 | NME1 | 3.16940178 |
| 10 | NEK1 | 2.87242880 |
| 11 | EIF2AK1 | 2.84723117 |
| 12 | TSSK6 | 2.82297590 |
| 13 | PIK3CG | 2.82291920 |
| 14 | AKT3 | 2.54728511 |
| 15 | TTK | 2.38197960 |
| 16 | NME2 | 2.26111566 |
| 17 | PLK4 | 2.22547611 |
| 18 | ZAK | 2.17087285 |
| 19 | TESK2 | 2.04505192 |
| 20 | IRAK3 | 2.02346479 |
| 21 | ARAF | 1.98894881 |
| 22 | SRPK1 | 1.88346406 |
| 23 | MAPK12 | 1.84695303 |
| 24 | PDK3 | 1.72173032 |
| 25 | PDK4 | 1.72173032 |
| 26 | MUSK | 1.58458125 |
| 27 | MAP2K3 | 1.58346950 |
| 28 | PIM2 | 1.52461024 |
| 29 | NEK2 | 1.52301751 |
| 30 | MAP3K7 | 1.49512630 |
| 31 | EIF2AK3 | 1.45753802 |
| 32 | PLK1 | 1.39293176 |
| 33 | MAP2K2 | 1.37794861 |
| 34 | BRSK2 | 1.37396210 |
| 35 | PDK2 | 1.37331351 |
| 36 | LMTK2 | 1.36238039 |
| 37 | BRAF | 1.29502347 |
| 38 | NUAK1 | 1.29091932 |
| 39 | MAP2K4 | 1.28661424 |
| 40 | MAPKAPK3 | 1.28047450 |
| 41 | PLK3 | 1.27984945 |
| 42 | PRKCI | 1.20476431 |
| 43 | BCKDK | 1.17749443 |
| 44 | FRK | 1.14887275 |
| 45 | STK38L | 1.09331068 |
| 46 | RPS6KB2 | 1.08698323 |
| 47 | AURKB | 1.05627847 |
| 48 | AURKA | 1.05279659 |
| 49 | MAP3K8 | 1.03630879 |
| 50 | MST4 | 0.98469756 |
| 51 | MAP3K11 | 0.98043293 |
| 52 | TRPM7 | 0.97500105 |
| 53 | EEF2K | 0.95775947 |
| 54 | ERBB3 | 0.92785669 |
| 55 | MOS | 0.90681962 |
| 56 | MST1R | 0.88542078 |
| 57 | PAK1 | 0.84991323 |
| 58 | CHEK2 | 0.83999761 |
| 59 | CCNB1 | 0.83283395 |
| 60 | DYRK1B | 0.82732462 |
| 61 | LIMK1 | 0.82453264 |
| 62 | PAK4 | 0.81797590 |
| 63 | DYRK3 | 0.81762612 |
| 64 | ACVR1B | 0.79076660 |
| 65 | STK24 | 0.78680486 |
| 66 | BRSK1 | 0.78502976 |
| 67 | TLK1 | 0.77587358 |
| 68 | ABL2 | 0.74887341 |
| 69 | PRKAA2 | 0.73731923 |
| 70 | PBK | 0.69537082 |
| 71 | VRK1 | 0.66852698 |
| 72 | MAP2K6 | 0.66085543 |
| 73 | MAP3K13 | 0.64074172 |
| 74 | DMPK | 0.63570626 |
| 75 | MARK1 | 0.61513349 |
| 76 | TESK1 | 0.58973359 |
| 77 | PINK1 | 0.57534357 |
| 78 | TAOK2 | 0.56633901 |
| 79 | CAMK4 | 0.55849090 |
| 80 | MAPK7 | 0.53476770 |
| 81 | MAP3K3 | 0.53211448 |
| 82 | CSNK2A1 | 0.52392529 |
| 83 | CDK4 | 0.51478881 |
| 84 | PRKG1 | 0.51037257 |
| 85 | EIF2AK2 | 0.50981743 |
| 86 | PKN1 | 0.49493198 |
| 87 | NEK9 | 0.48960597 |
| 88 | CAMK2G | 0.48851006 |
| 89 | CSNK2A2 | 0.48365218 |
| 90 | MAPK11 | 0.47334907 |
| 91 | KSR2 | 0.47319148 |
| 92 | LATS2 | 0.44888723 |
| 93 | KDR | 0.44408820 |
| 94 | ALK | 0.43269504 |
| 95 | CSNK1E | 0.42325927 |
| 96 | MAP2K1 | 0.41393082 |
| 97 | CAMK2A | 0.41318546 |
| 98 | MAPK4 | 0.40383926 |
| 99 | MARK3 | 0.39968063 |
| 100 | TIE1 | 0.39216577 |
| 101 | CDK19 | 0.39103291 |
| 102 | SGK3 | 0.38955692 |
| 103 | TAOK1 | 0.38509932 |
| 104 | MAPK13 | 0.37247311 |
| 105 | CAMK1 | 0.37045565 |
| 106 | PIK3CA | 0.36139773 |
| 107 | OBSCN | 0.35020577 |
| 108 | RIPK1 | 0.34491837 |
| 109 | ROCK1 | 0.34077304 |
| 110 | MAP3K1 | 0.33866363 |
| 111 | CAMK2D | 0.32504807 |
| 112 | CHEK1 | 0.32169861 |
| 113 | RPS6KB1 | 0.31957254 |
| 114 | ICK | 0.31826537 |
| 115 | SGK2 | 0.31262003 |
| 116 | PRKACA | 0.30652998 |
| 117 | CDK2 | 0.30619535 |
| 118 | ILK | 0.30299527 |
| 119 | DYRK2 | 0.30242184 |
| 120 | CDC7 | 0.29708354 |
| 121 | STK3 | 0.28242301 |
| 122 | PRKG2 | 0.28219545 |
| 123 | ATR | 0.27618711 |
| 124 | TRIB3 | 0.27401844 |
| 125 | CAMK2B | 0.26700209 |
| 126 | PIM1 | 0.25960935 |
| 127 | PRKACB | 0.25926471 |
| 128 | CDK7 | 0.25260769 |
| 129 | PRKAA1 | 0.25096300 |
| 130 | LRRK2 | 0.24981162 |
| 131 | STK4 | 0.24098291 |
| 132 | CSNK1A1 | 0.23991037 |
| 133 | RPS6KA3 | 0.23748390 |
| 134 | SGK1 | 0.23584973 |
| 135 | LATS1 | 0.22826612 |
| 136 | MELK | 0.22092184 |
| 137 | EPHB1 | 0.21761807 |
| 138 | MAPK10 | 0.21028475 |
| 139 | MKNK2 | 0.20158600 |
| 140 | SGK223 | 0.19211981 |
| 141 | SGK494 | 0.19211981 |
| 142 | AKT2 | 0.17837696 |
| 143 | RPS6KA1 | 0.17789164 |
| 144 | STK38 | 0.17318236 |
| 145 | NLK | 0.17256155 |
| 146 | CAMKK2 | 0.17102877 |
| 147 | IRAK2 | 0.16855464 |
| 148 | MYLK | 0.16268319 |
| 149 | MKNK1 | 0.16232253 |
| 150 | CDK1 | 0.16091638 |
| 151 | TBK1 | 0.16077821 |
| 152 | RAF1 | 0.13856814 |
| 153 | PDPK1 | 0.13620298 |
| 154 | RPS6KA5 | 0.13578778 |
| 155 | MAP3K4 | 0.12328486 |
| 156 | KSR1 | 0.10982348 |
| 157 | MAP2K7 | 0.10490690 |
| 158 | PRKACG | 0.10452505 |
| 159 | MARK2 | 0.10268907 |
| 160 | DAPK2 | 0.10023418 |
| 161 | SIK1 | 0.08767739 |
| 162 | MTOR | 0.07906367 |
| 163 | MAP3K9 | 0.07003460 |
| 164 | MAP3K6 | 0.06928098 |
| 165 | PDK1 | 0.06624176 |
| 166 | PRKD1 | 0.06025767 |
| 167 | CSNK1D | 0.05665624 |
| 168 | TNK2 | 0.05433250 |
| 169 | PAK6 | 0.05297600 |
| 170 | MAP3K5 | 0.04897594 |
| 171 | RPS6KC1 | 0.04857423 |
| 172 | RPS6KL1 | 0.04857423 |
| 173 | MAPK9 | 0.03508095 |
| 174 | GSK3B | 0.03180625 |
| 175 | PTK2B | 0.03135452 |
| 176 | CDK5 | 0.02610348 |
| 177 | MAP4K2 | 0.02389108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Proteasome_Homo sapiens_hsa03050 | 5.58340945 |
| 2 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 4.37068471 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 4.11437218 |
| 4 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.78032513 |
| 5 | RNA polymerase_Homo sapiens_hsa03020 | 3.33130834 |
| 6 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 3.21735367 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 3.20821523 |
| 8 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.69739617 |
| 9 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.55142569 |
| 10 | Regulation of autophagy_Homo sapiens_hsa04140 | 2.52909187 |
| 11 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 2.51651736 |
| 12 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 2.44534801 |
| 13 | RNA transport_Homo sapiens_hsa03013 | 2.31448281 |
| 14 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.22234295 |
| 15 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.19063863 |
| 16 | DNA replication_Homo sapiens_hsa03030 | 2.10557674 |
| 17 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 2.08152069 |
| 18 | Folate biosynthesis_Homo sapiens_hsa00790 | 2.05707927 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.01262181 |
| 20 | Mismatch repair_Homo sapiens_hsa03430 | 2.00306858 |
| 21 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.99638708 |
| 22 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.97545288 |
| 23 | * Insulin signaling pathway_Homo sapiens_hsa04910 | 1.89770190 |
| 24 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.88224925 |
| 25 | Parkinsons disease_Homo sapiens_hsa05012 | 1.83321422 |
| 26 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.81269724 |
| 27 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.80975626 |
| 28 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.73611334 |
| 29 | Spliceosome_Homo sapiens_hsa03040 | 1.73489562 |
| 30 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.68508604 |
| 31 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.68352860 |
| 32 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.62502424 |
| 33 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.60829061 |
| 34 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.60813829 |
| 35 | Homologous recombination_Homo sapiens_hsa03440 | 1.57185925 |
| 36 | Huntingtons disease_Homo sapiens_hsa05016 | 1.55170697 |
| 37 | Insulin resistance_Homo sapiens_hsa04931 | 1.54297220 |
| 38 | * Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.43406005 |
| 39 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.39602191 |
| 40 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.37156450 |
| 41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.36545127 |
| 42 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.36536493 |
| 43 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.35352907 |
| 44 | Purine metabolism_Homo sapiens_hsa00230 | 1.35037292 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.34981280 |
| 46 | Galactose metabolism_Homo sapiens_hsa00052 | 1.33750167 |
| 47 | Base excision repair_Homo sapiens_hsa03410 | 1.32008834 |
| 48 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.28518648 |
| 49 | * Carbon metabolism_Homo sapiens_hsa01200 | 1.26132943 |
| 50 | * Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.25747682 |
| 51 | Mineral absorption_Homo sapiens_hsa04978 | 1.22904406 |
| 52 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.21918968 |
| 53 | Sulfur relay system_Homo sapiens_hsa04122 | 1.20867183 |
| 54 | Cell cycle_Homo sapiens_hsa04110 | 1.20045196 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.18507426 |
| 56 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.17974828 |
| 57 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 1.17245723 |
| 58 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 1.15324661 |
| 59 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.11687414 |
| 60 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.10047004 |
| 61 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.09268525 |
| 62 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.08289327 |
| 63 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.07758388 |
| 64 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.04310845 |
| 65 | Alzheimers disease_Homo sapiens_hsa05010 | 1.03549956 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.03548343 |
| 67 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.03175372 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.01686477 |
| 69 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.99911973 |
| 70 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.96923853 |
| 71 | Basal transcription factors_Homo sapiens_hsa03022 | 0.96030562 |
| 72 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.95964662 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.94230393 |
| 74 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.94118056 |
| 75 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.94024146 |
| 76 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.93136016 |
| 77 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.93081515 |
| 78 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.90846504 |
| 79 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.90301665 |
| 80 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.86420963 |
| 81 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84084709 |
| 82 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.80957544 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.79748445 |
| 84 | Renin secretion_Homo sapiens_hsa04924 | 0.78100595 |
| 85 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.77533136 |
| 86 | Long-term potentiation_Homo sapiens_hsa04720 | 0.74260816 |
| 87 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.73175443 |
| 88 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70781721 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70046343 |
| 90 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.70033623 |
| 91 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.68378530 |
| 92 | Tight junction_Homo sapiens_hsa04530 | 0.65062248 |
| 93 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.64470080 |
| 94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.64064558 |
| 95 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.63189620 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.62701809 |
| 97 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.61973713 |
| 98 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.61861574 |
| 99 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.59605936 |
| 100 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.58669949 |
| 101 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.58294079 |
| 102 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.57478812 |
| 103 | RNA degradation_Homo sapiens_hsa03018 | 0.57299331 |
| 104 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.56369485 |
| 105 | Viral myocarditis_Homo sapiens_hsa05416 | 0.53516833 |
| 106 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.53432918 |
| 107 | Circadian entrainment_Homo sapiens_hsa04713 | 0.49089251 |
| 108 | Histidine metabolism_Homo sapiens_hsa00340 | 0.47856701 |
| 109 | Insulin secretion_Homo sapiens_hsa04911 | 0.47522928 |
| 110 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.44786513 |
| 111 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.44749965 |
| 112 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.43787175 |
| 113 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.43696688 |
| 114 | Focal adhesion_Homo sapiens_hsa04510 | 0.42050695 |
| 115 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.42015473 |
| 116 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.40250127 |
| 117 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.39581768 |
| 118 | Long-term depression_Homo sapiens_hsa04730 | 0.39547508 |
| 119 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.38469658 |
| 120 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.37191971 |
| 121 | Salivary secretion_Homo sapiens_hsa04970 | 0.36425813 |
| 122 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.36091723 |
| 123 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.34916713 |
| 124 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.34241170 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.30653281 |
| 126 | Peroxisome_Homo sapiens_hsa04146 | 0.28074128 |
| 127 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.27310756 |
| 128 | Olfactory transduction_Homo sapiens_hsa04740 | 0.27280084 |
| 129 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.26947420 |
| 130 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.25655086 |
| 131 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.25569824 |
| 132 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.23669344 |
| 133 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.22473330 |
| 134 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.22299158 |
| 135 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.22145004 |
| 136 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.20936848 |
| 137 | Circadian rhythm_Homo sapiens_hsa04710 | 0.20843501 |
| 138 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.20584315 |
| 139 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.19815007 |
| 140 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.19499719 |
| 141 | Protein export_Homo sapiens_hsa03060 | 0.19093706 |
| 142 | * Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.18203801 |
| 143 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.18040873 |
| 144 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.17865019 |
| 145 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.17560763 |
| 146 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.16917277 |
| 147 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.16680280 |
| 148 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.16420076 |
| 149 | Glioma_Homo sapiens_hsa05214 | 0.15129440 |
| 150 | Melanogenesis_Homo sapiens_hsa04916 | 0.14376144 |
| 151 | Phototransduction_Homo sapiens_hsa04744 | 0.14203640 |
| 152 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.12306841 |
| 153 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.10561915 |
| 154 | Adherens junction_Homo sapiens_hsa04520 | 0.10531208 |
| 155 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.10166557 |
| 156 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.10064519 |
| 157 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.08266410 |
| 158 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.05602377 |

